Bipolar disorder maintenance
First line
First-line in acute mania as monotherapy or with lithium/valproate per CANMAT 2018. Dose 2–6 mg once daily. Long-acting injectable is preferred for maintenance of bipolar disorder.
Atypical antipsychotic – dopamine and serotonin receptor antagonist
ATC code: N05AX08 (Risperidone)
A dopamine D2 and serotonin 5-HT2A receptor antagonist. Suppresses positive schizophrenia symptoms via mesolimbic D2 blockade and negative symptoms via prefrontal 5-HT2A. Compared with typical antipsychotics (haloperidol), less extrapyramidal disorder but more prolactin elevation than other atypicals. Active metabolite 9-hydroxyrisperidone (paliperidone) is itself registered as a separate drug. Half-life 20 hours.
First line
First-line in acute mania as monotherapy or with lithium/valproate per CANMAT 2018. Dose 2–6 mg once daily. Long-acting injectable is preferred for maintenance of bipolar disorder.
First line
First-line for schizophrenia per 2020 and NG178 (2020). Starting dose 2 mg once daily, titrated to 4–6 mg. Long-acting injectable Risperdal Consta 25–50 mg every 2 weeks for patients with adherence issues. The Huhn 2019 network meta-analysis showed one of the highest efficacies among atypical antipsychotics, but a worse side-effect profile than aripiprazole – more prolactinemia, metabolic disturbance, and extrapyramidal effects at high doses.
The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.
Not recommended
Risperidone is an antipsychotic, not a sleep medication. It is prescribed for schizophrenia, bipolar disorder, and behavioral problems in children with autism spectrum disorder ( 2020 and NG178 guidelines). For common insomnia, risperidone does not work: its effect on sleep is a side effect, not therapeutic. The drug carries serious risks: extrapyramidal symptoms (tremor, muscle stiffness), metabolic syndrome, hyperprolactinemia. In elderly patients with dementia, it increases mortality ( boxed warning). If risperidone was prescribed for insomnia, consider seeking a second opinion.
Not recommended
Risperidone is an antipsychotic, not an anxiolytic. It is prescribed for schizophrenia, bipolar disorder, and behavioral problems in children with autism spectrum disorder ( 2020 and NG178 guidelines). For acute stress, risperidone does not work: no clinical studies of such use exist. The drug has serious side effects: extrapyramidal symptoms (tremor, muscle stiffness), metabolic syndrome, hyperprolactinemia. In elderly patients with dementia, it increases mortality ( boxed warning). If risperidone was prescribed for stress, consider seeking a second opinion.
Opens the checker prefilled with this drug. Pick the second one from your regimen.
Direct links to regulator labels. Open in a new tab.
Boxed warning
FDA boxed warning: increased mortality in elderly patients with dementia treated with atypical antipsychotics. Not for dementia-related psychosis.
T3 use carries neonatal extrapyramidal and withdrawal risk. In pregnant psychotic patients, decisions are made with the psychiatrist.
Moderate milk concentrations. Use during lactation under monitoring of infant sedation, weight gain, and extrapyramidal symptoms.
Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.
Risperidone is evaluated for the following indications with varying evidence strength: Bipolar disorder maintenance (evidence tier A), Schizophrenia (evidence tier A), Insomnia and sleep disorders (evidence tier F). See the full indication matrix with dosing and citations above on this page.
Common side effects of Risperidone (≥ 1 in 100): Drowsiness, Weight gain (moderate), Hyperprolactinemia (galactorrhea, amenorrhea, sexual dysfunction), Extrapyramidal effects at doses over 6 mg, Orthostatic hypotension, Constipation. See the Safety section for uncommon and serious reactions.
FDA category C. T3 use carries neonatal extrapyramidal and withdrawal risk. In pregnant psychotic patients, decisions are made with the psychiatrist.
Moderate milk concentrations. Use during lactation under monitoring of infant sedation, weight gain, and extrapyramidal symptoms.
Risperidone is contraindicated in: Risperidone hypersensitivity; Dementia in older adults (raised stroke and mortality risk); Parkinson's disease, Lewy body dementia (worsening risk); QT prolongation; Pregnancy – with caution. Full list in the Safety section.
FDA boxed warning: increased mortality in elderly patients with dementia treated with atypical antipsychotics. Not for dementia-related psychosis.